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How pathogenic cluster of differentiation 4 (CD4) T cells in
rheumatoid arthritis (RA) develop remains poorly understood. We
used Nur77—a marker of T cell antigen receptor (TCR) signaling—
to identify antigen-activated CD4 T cells in the SKG mouse model
of autoimmune arthritis and in patients with RA. Using a fluores-
cent reporter of Nur77 expression in SKG mice, we found that
higher levels of Nur77-eGFP in SKG CD4 T cells marked their autor-
eactivity, arthritogenic potential, and ability to more readily dif-
ferentiate into interleukin-17 (IL-17)–producing cells. The T cells
with increased autoreactivity, nonetheless had diminished ex vivo
inducible TCR signaling, perhaps reflective of adaptive inhibitory
mechanisms induced by chronic autoantigen exposure in vivo. The
enhanced autoreactivity was associated with up-regulation of IL-6
cytokine signaling machinery, which might be attributable, in part,
to a reduced amount of expression of suppressor of cytokine sig-
naling 3 (SOCS3)—a key negative regulator of IL-6 signaling. As a
result, the more autoreactive GFPhi CD4 T cells from SKGNur mice
were hyperresponsive to IL-6 receptor signaling. Consistent with
findings from SKGNur mice, SOCS3 expression was similarly down-
regulated in RA synovium. This suggests that despite impaired TCR
signaling, autoreactive T cells exposed to chronic antigen stimula-
tion exhibit heightened sensitivity to IL-6, which contributes to the
arthritogenicity in SKG mice, and perhaps in patients with RA.
antigen receptor signaling | T cells | Nur77 | autoimmunity |
rheumatoid arthritis
Rheumatoid arthritis (RA) is a chronic, destructive autoim-mune disease that targets both joints and other organs.
Cluster of differentiation 4 (CD4) T cells have long been ap-
preciated as playing a crucial role in the pathogenesis of RA (1–4).
Cellular and biochemical analyses of human CD4 T cells have
revealed abnormal T cell antigen receptor (TCR) signaling in
RA patients (5–8). Surprisingly, CD4 T cells from patients with
RA are hyporesponsive to TCR engagement ex vivo, as evi-
denced by reduced calcium mobilization and interleukin-2 (IL-2)
production (9, 10). This may be due, in part, to reduced TCRζ
and linker of activated T cells (LAT) expression, as well as cel-
lular changes associated with immune senescence (6, 7, 11–16).
Although CD4 T cells from patients with RA seem to have de-
creased signaling capacity when stimulated in vitro, they appear
to hyperproliferate during clonal expansion and differentiate
into effector cells that drive disease (17, 18). It is not currently
understood how to reconcile these paradoxical observations of
diminished TCR signaling in the setting of increased T cell
proliferation and effector functions, and it is not clear whether
this RA T cell phenotype is directly causal in disease patho-
genesis or rather results from exposure to chronic inflammation.
The inability to identify relevant arthritogenic T cells in patients
and in murine disease models has limited our understanding of
disease-initiating events in RA. In this report, we have developed
a strategy to overcome this limitation by taking advantage of the
dynamic expression pattern of Nur77(Nr4a1) in T cells.
Nr4a1 is an immediate early gene that encodes the orphan
nuclear hormone receptor Nur77. It is rapidly and robustly up-
regulated by TCR, but not cytokine, stimulation (19, 20).
Therefore, Nur77 expression in murine and human T cells
serves as a specific marker of TCR signaling but is insensitive to
cytokine stimulation (21–24). Detection of Nur77 expression
can be used to identify T cells stimulated by direct self-antigen
exposure prior to disease initiation as well as in the context of
complex immune responses and chronic autoimmune diseases
in which inflammatory cytokines can influence T cell pheno-
types. Indeed, gene expression data show that endogenous Nr4a1
transcripts are highly up-regulated in autoantigen-specific CD4 T
cells in vivo in the context of bona fide autoimmune disease
(Immunological Genome Project; http://www.immgen.org/; ref.
25). This suggested to us that Nur77 expression could be employed
to identify autoantigen-specific CD4 T cells in RA.
SKG mice harbor a profoundly hypomorphic variant of the
Zap70 cytoplasmic tyrosine kinase, a molecule that is critical for
proximal TCR signal transduction. As a consequence, SKG mice
exhibit impaired thymocyte negative selection, giving rise to
T cells with a more potentially autoreactive TCR repertoire (26).
In response to either an innate immune stimulus in the form of
zymosan injection or adoptive transfer of CD4 T cells into
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lymphopenic hosts, tolerance is broken and mice develop an
erosive inflammatory arthritis that resembles RA. For example,
rheumatoid factor, anti-cyclic citrullinated peptide (CCP) anti-
bodies, and interstitial lung inflammation develop at the onset of
disease (26). The SKG mouse provides a useful model to study
early events in RA pathogenesis; not only does it capture many
important features of human RA but SKG also offers 2 advan-
tages over other RA models. First, unlike the more commonly
used collagen-induced arthritis (27) or K/BxN serum-transfer
models of arthritis, which both bypass the initial break in TCR
tolerance (28), the SKG mice exhibit a loss in central, and likely
peripheral, tolerance that can be molecularly dissected. Hence,
this model uniquely allows us to study arthritis-causing T cells
both before and during disease. Second, it recapitulates the
paradoxical ability of RA CD4 T cells to differentiate into
pathogenic effector cells despite impaired TCR signaling (6, 7,
11–18, 26).
A recent study of the SKG model has identified 1 specific
arthritogenic TCR directed against a ubiquitous self-antigen (29),
but it is not known whether rare antigen-specific T cell clones
drive disease or whether the entire preimmune TCR repertoire
has arthritogenic potential because it is highly autoreactive. It is
also not clear how tolerance of such clones is broken in the face
of profoundly depressed TCR signaling in SKG mice. To address
these questions, we backcrossed the Nur77-eGFP bacterial arti-
ficial chromosome (BAC) transgenic (Tg) reporter line [in which
eGFP protein expression is under the control of the Nr4a1 reg-
ulatory region (24)] onto the SKG mouse model of arthritis. The
resulting so-called SKGNur mice provided us with a tool to fa-
cilitate identification and study of arthritogenic CD4 T cells both
before and after disease initiation. Despite impaired TCR signal
transduction, the peripheral naive CD4 T cells from SKG mice
expressed higher levels of Nur77-eGFP relative to those of wild-
type (WT) mice. This suggested that even before disease initia-
tion, SKG mice harbor a profoundly autoreactive T cell repertoire
that exhibits increased downstream signaling despite impaired
Zap70 function. We show here that the amount of Nur77-eGFP
expression in CD4 T cells from SKG mice correlated with both
their autoreactivity and their arthritogenicity. We found that the
SKGNur CD4 T cells that expressed the highest level of the
Nur77-eGFP reporter (GFPhi) differentiated more readily into IL-
17–producing cells in vivo. While examining why GFPhi cells were
predisposed to differentiate into T helper 17 (Th17) effector
T cells, we observed profoundly enhanced IL-6–dependent sig-
naling in GFPhi CD4 T cells from SKG mice. Apparently, the
autoimmune repertoire, despite being coupled with impaired TCR
signal transduction capacity in the SKG model, resulted in re-
duced expression of suppressor of cytokine signaling 3 (SOCS3), a
key negative regulator of IL-6 signaling. Likewise, we found
SOCS3 expression was down-regulated in RA synovium. This, in
turn, suggests that despite impaired TCR signaling, autoreactive
T cells exposed to chronic antigen stimulation exhibit heightened
sensitivity to IL-6 receptor (IL-6R) signaling, which contributes
to their arthritogenicity in SKG mice, and perhaps in patients
with RA.
Results
A Fluorescent Reporter of TCR Signaling Reveals and Marks Self-
Reactivity of the CD4 T Cell Repertoire in SKG Mice. We sought to
take advantage of a transcriptional reporter of Nr4a1 expression
in order to examine antigen-specific signaling in pathogenic SKG
T cells. Since Nur77 expression is induced downstream of TCR,
but not cytokine receptor, signaling (21, 23, 24), it can serve as a
specific reporter of antigen receptor signaling in T cells in vitro
or in vivo (21–24). We backcrossed the Nur77-eGFP BAC Tg
reporter (24) into either WT or SKG mice, both on the BALB/c
background (hereafter referred to as WTNur or SKGNur, re-
spectively). We confirmed that the introduction of the Nur77-
eGFP BAC Tg reporter into the SKG mouse model did not al-
ter the phenotype. Indeed, the SKGNur CD4 T cells continued to
demonstrate dramatic hyporesponsiveness to in vitro polyclonal
TCR stimulation, consistent with published data (26, 30), and
developed a severe inflammatory and erosive arthritis after zy-
mosan challenge (SI Appendix, Fig. S1 A–C).
It has previously been shown that thymic negative selection is
quite impaired in SKG mice because TCR signaling is excep-
tionally dampened (26). As a result, highly autoreactive T cells,
which would ordinarily be deleted, are instead positively se-
lected. Although 1 SKG autoreactive TCR has been cloned (29),
it remains unknown whether rare antigen-specific T cell clones
drive disease or whether the entire repertoire has arthritogenic
potential because it is highly autoreactive. The Nur77-eGFP
distribution in SKG mice is broad and overlaps with the distri-
bution seen in normal mice (Fig. 1 A and B). Following stimula-
tion with zymosan, which induces arthritis, there is an enrichment
of Nur77-eGFP–expressing CD4 T cells with higher levels of GFP
in draining popliteal nodes, but the distribution of GFP is still
quite broad and largely overlaps with that of cells from untreated
SKG mice. The Nur77-eGFP expression in CD4 T cells isolated
from the arthritic joints of SKG mice, however, is substantially
increased but still overlaps with the expression distribution in CD4
T cells from untreated mice (Fig. 1A and gating in SI Appendix,
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Fig. 1. Nur77 reporter of TCR signaling marks the selection of an autoreactive
repertoire during thymic development with further pruning in the periph-
ery. (A) Assessment of Nur77-eGFP fluorescence in SKGNur CD4+CD25− T cells
freshly isolated from popliteal lymph nodes (LNs) ± phosphate-buffered
saline (PBS) or zymosan (Zym) and arthritic joints (+Zym). Data are repre-
sentative of 10 mice in 4 independent experiments. (B) Comparison of ex-
pression of Nur77-eGFP and CD5 in preselection (pre; CD69loTCR-βlo) and
postselection (post; CD69hiTCR-βhi) double-positive (DP), CD4SP (CD4+CD3hiTCRβhi)
thymocytes, and peripheral CD4+CD25− naive (CD62LhiCD44lo) and memory
(CD44hiCD62Llo) and CD4+CD25+ Treg lymphocytes. Results are representative
of 2 independent experiments with 6 mice in each group. (C) Depiction of
AMLR workflow. (D and E) Sorted CD4+CD25− naive (CD62LhiCD44lo) GFPlo and
GFPhi T cells were loaded with CTV dye and cocultured with nonirradiated
APCs from BALB/c mice for 5 d. (D) Cells were subsequently stained for T-cell
markers and assessed for dye dilution by flow cytometry.*P < 0.05; **P < 0.01.
ns, not significant. (E) Box plots represent percent (%) division of GFPlo and
GFPhi CD4 T cells as assessed using the Flow Jo v9 proliferation platform (center
line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile
range). Representative histograms of CTV dilution (D) and % cell division (E)
from 4 experimental replicates (each containing 2 to 3 pooled mice) are
shown. (F) Histograms represent Ki67 proliferation marker staining in GFPlo
and GFPhi CD4+CD25− naive (CD62LhiCD44lo) or memory (CD44hiCD62Llo)
T cells. In C and E, a 2-tailed Student’s t test was used.
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Fig. S1D). This suggests that the T cell repertoire prior to and
after zymosan stimulation has a broad distribution but that the
arthritogenic potential may not be limited to a narrow spectrum of
autoreactive cells. This could account for the failure to identify a
unique dominant arthritogenic TCR in this model to date (29).
We took advantage of SKGNur mice to study this further.
We first used the Nur77-eGFP reporter to assess differences in
TCR signaling between WT and SKG T cells during T cell de-
velopment, as it seemed likely that a more autoreactive reper-
toire was being positively selected by the self-peptide major
histocompatibility complex (pMHC) in SKG mice. The surface
marker CD5 is dependent on p56lck activity throughout T cell
development and is frequently used as an indicator of TCR
signaling strength during and after thymic development (31). We
assessed both CD5 and Nur77-eGFP expression at sequential
stages of T cell development in WTNur and SKGNur mice.
Consistent with impaired TCR signaling in SKG mice as iden-
tified in previous studies, preselection double-positive thymo-
cytes from SKGNur mice exhibited lower levels of both GFP and
CD5 relative to those of WTNur (Fig. 1B and SI Appendix, Fig.
S2A). Prior work has identified a minimal threshold of TCR
signaling that is necessary for positive selection (32). Consistent
with this, after the positive selection checkpoint, GFP and CD5
were markedly up-regulated in postselection thymocytes in both
WTNur and SKGNur mice. Of note, GFP expression levels
in SKGNur CD4 single-positive (CD4SP) thymocytes became
equivalent to WTNur, whereas CD5 expression remained re-
duced in SKGNur CD4SP thymocytes (Fig. 1B and SI Appendix,
Fig. S2A). Since TCR signaling is markedly dampened in SKG
mice, high GFP expression in SKGNur CD4SP thymocytes im-
plies selection of a highly autoreactive repertoire where strong
stimulation by self-pMHC complexes compensates for impaired
signal transduction in order to support positive selection (32).
Surprisingly, we found that some peripheral naive and memory
CD4 lymphocytes from SKGNur mice had somewhat higher
GFP levels than WTNur controls (Fig. 1B and SI Appendix, Fig.
S2A). Note that regulatory T cells (Tregs), which are selected on
the basis of self-reactivity during development and consequently
express high levels of Nur77 (23) (Fig. 1B), were excluded in this
analysis. This suggested to us that autoreactive SKG T cells were
either exposed to chronic autoantigen stimulation in the pe-
riphery or underwent further repertoire pruning under the in-
fluence of autoantigens and weak TCR signaling, or both. In
contrast, CD5 surface expression remained lower in SKGNur
peripheral CD4 T cells compared with controls (Fig. 1B and SI
Appendix, Fig. S2A). It is unclear why CD5 and Nur77 expression
levels were discordant following positive selection and in the
periphery. However, CD5 is frequently used as a marker of
proximal TCR signaling strength involving interactions with Lck
and Cbl with the CD5 cytoplasmic tail (9, 33, 34). In contrast,
Nur77 is reflective of transcriptional activation that is regulated
by tonic and integrated downstream TCR signaling pathways
(35). Thus, we used Nur77-eGFP as a marker of TCR signaling
in SKG peripheral T cells as it appeared to be a reliable marker
of not only strength of transduced TCR signal but integrated
TCR signaling reflective of antigen encounter in vivo over time.
Nur77-eGFP High-Expressing CD4 T Cells Are Phenotypically Different
from GFP Low-Expressing T Cells from WTNur and SKGNur Mice.
Given the broad distribution of Nur77-eGFP expression, we
asked whether the extreme ends of the histogram represented
phenotypic differences or differences in T cell subsets. To examine
this, we compared the surface expression of T cell activation
markers in the 10% highest and 10% lowest Nur77-eGFP–
expressing subsets (hereafter referred to as GFPhi and GFPlo,
respectively) from the total CD4 T cell population of WTNur and
SKGNur mice. We found the GFPhi CD4 T cells expressed the
highest levels of CD5, CD25, and CD69 from both strains of mice
(SI Appendix, Fig. S3A). To determine the percentage of memory
(CD44hiCD62Llo) and naive (CD62LloCD44hi) T cell subsets in
the total CD4 T cells and GFPhi and GFPlo populations, CD25+
T cells were gated out to exclude Tregs. SKGNur mice had reduced
naive and expanded memory T cells compared with WTNur mice
(SI Appendix, Fig. S3 B and C). Although there were some differ-
ences in naive and memory subsets between GFPhi and GFPlo
populations from WTNur mice, the largest differences were ob-
served between GFPhi and GFPlo populations from SKGNur mice,
with a significantly lower percentage of naive and a higher per-
centage of memory T cells in the GFPhi population (SI Appendix,
Fig. S3 B and C). Since CD25+ T cells were primarily in the
GFPhi population, we sought to determine how well this reflected
the FoxP3+ Treg population. GFPhi CD4 T cells from both WTNur
and SKGNur mice were significantly enriched for FoxP3+ Tregs
and were expressed in a significantly higher percentage in both
subsets from SKGNur mice compared with WTNur controls (SI
Appendix, Fig. S3 D–F).
Nur77-eGFP High-Expressing SKGNur CD4 T Cells Demonstrate
Increased Autoreactivity. In view of the discordant expression of
Nur77-eGFP and CD5 in peripheral CD4 T cells from SKGNur
mice and the broad distribution of Nur77-eGFP expression, we
sought to take an independent approach to probe the putative
self-reactivity of the mature repertoire and whether Nur77-eGFP
expression marked differences in the self-reactivity of this rep-
ertoire. We compared the response of CD4+CD25− naive T cells
sorted for the 10% highest and 10% lowest Nur77-eGFP expres-
sion to determine whether reporter expression reflected repertoire
differences and/or interactions with self-pMHC among the poly-
clonal CD4 T cells. Sorted CD4+CD25− GFPhi and GFPlo naive
T cells from SKGNur and WTNur mice were challenged in an
in vitro autologous mixed lymphocyte reaction (AMLR). Sorted
cells were stained with Cell Trace Violet (CTV) and incubated
in vitro with WT BALB/c splenocytes for 5 d in culture, and
proliferation was assessed by CTV dye dilution (Fig. 1C). WTNur
T cells are not expected to mount a response in this assay because
of efficient tolerance induction during thymic negative selection.
Indeed, as expected, neither GFPhi nor GFPlo CD4 T cells from
WTNur mice mounted substantial proliferative responses. How-
ever, SKGNur GFPhi CD4+CD25− naive T cells exhibited at least
a 4-fold greater in vitro proliferative response to autologous
BALB/c antigen-presenting cells (APCs) compared with SKG-
GFPlo CD4 T cells (Fig. 1 D and E). The ability of SKG T cells
to proliferate in an autologous AMLR has previously been shown
to be MHC class II-dependent (36) and suggests that SKGNur
GFPhi CD4 T cells are indeed enriched for cells with self-reactive
TCRs, and that the degree of autoreactivity is sufficient to over-
come impaired TCR signal transduction conferred by the SKG
Zap70 hypomorphic allele.
We then assessed GFPhi and GFPlo CD4 T cell populations
from WTNur and SKGNur mice for evidence of an in vivo cor-
relate of the in vitro proliferative response. As shown in Fig. 1F,
we compared Ki-67 expression in both naive and memory CD4
T cells from WTNur and SKGNur mice. As expected, under
steady-state conditions, virtually no naive WT T cells were pro-
liferating, and Ki67 expression was virtually undetectable in both
GFPhi and GFPlo CD4 T cells from WTNur mice. However, a
substantial proportion of naive and memory T cells from SKG
mice were Ki-67+, consistent with a previous 5-bromodeoxyuridine
labeling study in which SKG CD4 T cells were shown to have high
in vivo proliferative activity (36). Importantly, the proliferating
fraction was almost exclusively found among GFPhi cells, sug-
gesting that Nur77-eGFP expression indeed marks a functionally
distinct CD4 T cell population in the periphery of SKGNur mice,
presumably driven, at least in part, by stronger recognition of self-
pMHC in vivo and in vitro. Moreover, this functional heteroge-
neity is identifiable by the extent of the Nur77-eGFP reporter
expression before frank disease onset.
Since both cytokine and self-pMHC–TCR interactions are
essential for homeostatic T cell proliferation (37–39), we wanted
to investigate whether differences in IL-7 responsiveness contrib-
uted to increased proliferation of GFPhi SKGNur CD4 T cells
under steady-state conditions. Interestingly, GFPhi CD4 T cells are
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relatively insensitive to IL-7 signaling in comparison to GFPlo
CD4 T cells from both SKGNur and control mice as assessed by
phosphorylation of signaling transducer and activator of tran-
scription 5 (STAT5) upon treatment with IL-7 (SI Appendix, Fig.
S4A). This result also correlated with lower levels of IL-7Rα
(CD127) on GFPhi compared with GFPlo CD4 T cells (SI Ap-
pendix, Fig. S4B). These data further support functional hetero-
geneity among the SKG T cell repertoire but do not account for
increased proliferation of SKGNur GFPhi CD4 T cells at steady
state, implying instead a role for antigen-dependent TCR signaling.
Nur77-eGFP Expression in SKGNur CD4 T Cells Strongly Correlates
with Their Arthritogenic Potential. Since the Nur77-eGFP re-
porter appeared to mark more autoreactive T cells, we next
asked whether this, in turn, correlated with their capacity to drive
arthritis. We used an adoptive transfer model of arthritis (26, 40,
41) to determine whether reporter expression identified a more
arthritogenic population of CD4 T cells. In this model, CD4
T cells transferred from SKG mice, but not from sera or CD8 or
B cells, are sufficient to cause arthritis (26). As delineated in Fig.
2A, CD4+CD25− GFPhi and GFPlo naive T cells were sorted and
adoptively transferred into severe combined immunodeficient
(SCID) recipients. Initially, we found that, with sufficient time
(>6 wk posttransfer), both GFPhi and GFPlo CD4 SKG T cells
were capable of producing arthritis upon transfer to lymphopenic
hosts, while WT T cells were not. This suggested that the entire
SKG T cell repertoire harbors T cells with pathogenic potential.
Therefore, we next sought to evaluate whether a difference in
onset and severity could be histologically detected. Indeed,
transfer of CD4+CD25− naive T cells expressing the highest
levels of GFP (GFPhi) resulted in an earlier onset (14 d after
adoptive transfer) and more severe arthritis in recipient SCID
mice than did the transfer of GFPlo naive CD4 T cells (Fig. 2 B
and C). This was characterized by increased synovial proliferation,
inflammatory infiltrates, and early cartilage destruction (Fig. 2 B,
white arrows and C). This was not observed in SCID mice that
received either SKGNur GFPlo CD4+CD25− naive T cells or
WTNur GFPhi or GFPlo CD4+CD25− naive T cells, where the thin
layer of synovial lining is maintained and infiltrating inflammatory
cells are absent (Fig. 2 B, black arrows and C). To assess whether
these results were unique to the naive SKGNur GFPhi CD4 T cell
population, the adoptive transfer experiment was repeated after
sorting for GFPhi and GFPlo CD4+CD25− memory T cells (SI
Appendix, Fig. S5A). We likewise found that the SKGNur GFPhi
CD4+CD25− memory T cells were capable of producing a more
severe and earlier onset of arthritis than SKGNur GFPlo T cells or
BALB/c WTNur control T cells (SI Appendix, Fig. S5B). We
conclude that arthritogenicity is a property of the entire SKG CD4
T cell repertoire but that T cells have varying arthritogenic po-
tential, and, most importantly, that this arthritogenic potential can
be identified by the amount of Nur77-eGFP expression and re-
flects their degree of self-reactivity.
Since the GFPhi population in SKGNur mice had greater ar-
thritic potential, we asked whether the GFPhi population exhibited
T cell effector functions distinct from those of the GFPlo population
in SKGNur mice. To address this question, we determined their
ability to generate IL-17 in vitro by stimulating sorted primary naive
T cell populations with plate-bound anti-CD3 and CD28. Notably,
we found that the percentages of IL-17–producing cells were 5-
to 10-fold higher in the SKGNur GFPhi population than in the
SKGNur GFPlo population. However, the difference in IL-17
production between GFPhi and GFPlo populations from WTNur
mice was almost indistinguishable (SI Appendix, Fig. S5C). To
determine whether this difference could be detected in our adop-
tive transfer model, transferred naive or memory CD4 T cells re-
covered from the recipient SCID mice were stimulated for 5 h ex
vivo with phorbol myristate acetate (PMA) and ionomycin in the
presence of brefeldin A to identify Th17 effector T cells capable
of secreting IL-17. CD4 T cells recovered from SCID recipient
mice that received SKGNur GFPhi naive or memory CD4 T cells
had a significantly higher percentage of such IL-17–producing
T cells than their GFPlo counterparts (Fig. 2D and SI Appen-
dix, Fig. S5D). This increase in IL-17–producing cells was not
observed in the CD4 T cells recovered from SCID mice that
received WTNur GFPhi or GFPlo CD4 T cells. Collectively, our
results suggest that the arthritogenic capacity of SKG CD4
T cells can be distinguished by their relative expression of Nur77-
eGFP before disease onset, and corresponds to increased
autoreactivity and proclivity to differentiate into pathogenic IL-
17–secreting effectors in vitro and in vivo.
Autoreactive Nur77-eGFPhi SKG T Cells Signal Poorly in Response to
TCR Stimulation. We next sought to understand why arthritogenic
GFPhi SKG T cells preferentially differentiated into Th17 ef-
fectors. Since GFP levels reflect integrated TCR signaling, we
hypothesized that differences in TCR signaling by this pop-
ulation of T cells may contribute to their Nur77-eGFP amounts
(Fig. 3A). We already showed that GFPhi SKG T cells are more
self-reactive, and therefore likely encounter more antigen in vivo
(Fig. 1 D and E). We next wanted to determine whether cell-
intrinsic capacity to signal downstream of their TCRs differed
between GFPhi and GFPlo T cells. To test this, we probed signaling
events downstream of the TCR. By removing cells from in vivo
antigen exposure and treating them with the polyclonal stimulus
α-CD3 in vitro, we were able to bypass any differences in TCR
repertoire between the GFPhi and GFPlo CD4 T cell subsets. We
first analyzed TCR-induced increases in cytoplasmic free calcium
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in peripheral naive T cells. SKGNur CD4+CD25− T cells, irre-
spective of GFP expression, demonstrated profoundly dampened
TCR-induced increases in cytoplasmic free calcium, consistent
with the hypomorphic SKG Zap70 allele (Fig. 3B and SI Appendix,
Fig. S1A). The calcium responses of GFPhi SKGNur CD4 T cell
responses were even more dampened than those of GFPlo CD4
T cells (Fig. 3B). Interestingly, an analogous trend was seen with
GFPhi WTNur CD4 T cells relative to GFPlo WTNur CD4 T cells,
suggesting that increased integrated TCR signaling input is asso-
ciated with dampened downstream TCR signal transduction.
Analysis of TCR-induced extracellular signal-regulated kinase
(ERK) phosphorylation in purified peripheral CD4 T cells sim-
ilarly revealed that both GFPhi and GFPlo CD4+CD25− SKGNur
T cells had a severe impairment in ERK phosphorylation after
polyclonal TCR stimulation. This was observed in both the
memory and naive peripheral CD4 T cell compartments (Fig. 3C
and SI Appendix, Fig. S1B). By contrast, ERK activation in re-
sponse to PMA, which bypasses TCR signaling, was normal,
consistent with the well-defined role of Zap70 in regulating only
proximal TCR signal transduction. In WTNur mice, GFPhi CD4
T cells appeared to have subtly decreased signaling capacity
compared with GFPlo T cells, but the responses were still largely
preserved, contrasting with the markedly impaired SKG responses
(Fig. 3C). Similarly, GFPhi, more than GFPlo, CD4+CD25− SKGNur
T cells had severely dampened phosphatidylinositol 3-kinase (PI3K)/
Akt signaling downstream of polyclonal TCR stimulation as ana-
lyzed by S6 phosphorylation at Ser240/244 (Fig. 3D). Likewise,
althoughWTNur GFPhi CD4 T cells exhibited a slightly dampened
response compared with GFPlo CD4 T cells, PI3K/Akt signaling
downstream of TCR stimulation was much more robust in WTNur
cells when compared with SKGNur cells (Fig. 3D). Consistent with
our calcium mobilization and phospho-flow studies, sorted
GFPlo CD4+CD25− naive CD4 T cells from both SKGNur and
WTNur mice proliferated more robustly to plate-bound αCD3
stimulation than GFPhi naive CD4 T cells (Fig. 3E). Moreover,
SKGNur CD4 T cells exhibited a clear proliferative defect in re-
sponse to plate-bound αCD3 stimulation as previously described
(30), which stands in marked contrast to SKGNur GFPhi naive
CD4 T cells’ ability to proliferate in response to self-antigen (Fig. 1
D and E). Therefore, these results indicate that differences in GFP
expression between the most and least arthritogenic SKGNur
CD4 T cells are not attributable to signal transduction machinery
but most likely reflect TCR autoreactivity to self-pMHC (antigen
recognition), although the possibility of differential cytokine
sensitivity contributing to proliferative differences cannot com-
pletely be excluded. It is possible that down-modulation of TCR
signal strength in GFPhi relative to GFPlo CD4 T cells could
represent a compensatory peripheral tolerance mechanism to
prevent inappropriate activation of self-reactive clones. Collec-
tively, these results suggest that differences in the measured TCR
signal transduction events do not account for the unique pro-
pensity of GFPhi CD4 T cells from SKGNur mice to differentiate
in vivo and in vitro into Th17 effectors.
Up-Regulation of Several Inhibitory Receptors in SKG GFPhi Cells. It
was quite surprising that GFPhi CD4 T cells from SKGNur mice
were able to exert their effector functions leading to joint im-
munopathology despite their profound impairment to in vitro
TCR signal transduction (Fig. 3 B–D). To account for the dis-
crepancy between arthritogenic and signaling potential of the
GFPhi cells as detected here, we next asked whether GFPhi CD4
T cells from SKGNur mice expressed much lower levels of in-
hibitory receptors, thereby permitting them to expand more
rapidly in a lymphopenic environment, or whether they expressed
higher levels of inhibitory receptors, further compromising their
impaired TCR signaling capacity compared with GFPlo CD4
T cells. To address this, we examined the surface expression of
several inhibitory receptors (PD-1, TIGIT, and CD73) that have
been shown to dampen downstream TCR signaling, the last of
which marks “anergic” T cell populations (42). GFPhi CD4 T cells
expressed higher levels of these inhibitory receptors than their
GFPlo counterparts, again suggesting that this may represent a
compensatory tolerance mechanism to constrain self-reactive
T cells (Fig. 4). However, higher expression levels of inhibitory
receptors observed in the GFPhi population were not unique to
SKGNur T cells since WTNur GFPhi CD4 T cells also had higher
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levels of inhibitory receptors compared with WTNur GFPlo CD4
T cells. This is consistent with a recent report demonstrating that
NR4A gene expression positively correlated with PDCD1 (PD-1),
TIGIT, and other inhibitory receptors in the setting of chronic
antigen stimulation as part of a T cell-intrinsic program of hypo-
responsiveness (43). In addition to CD73, folate receptor 4 (FR4)—
another marker used to identify anergic T cells—was enriched
in the GFPhi populations from WTNur and SKGNur mice (SI
Appendix, Fig. S6A). Therefore, phenotypically anergic cells were
compared between genotypes. While there did not appear to be a
significant difference between the percentage of total anergic
T cells between WTNur and SKGNur mice, the GFPhi T cells
were clearly enriched for T cells with an anergic phenotype, albeit
not as robustly in the SKGNur mice as in the WTNur mice (SI
Appendix, Fig. S6 B and C). Together, these results may account,
in part, for the relative hyporesponsiveness we observed in GFPhi
T cells (Fig. 3 B–E). Therefore, it is all the more striking that
SKGNur GFPhi CD4 T cells up-regulate inhibitory pathway re-
ceptors; appear to be enriched for phenotypically anergic cells;
and yet, despite this, exhibit the capability to proliferate in re-
sponse to autologous APCs, differentiate into IL-17–producing
cells, and cause more severe arthritis.
Enhanced IL-6 Response in GFPhi CD4 T Cells from SKGNur Mice. Th17
differentiation depends not only on TCR signaling in response to
pMHC but also on polarizing cytokines. Given the critical role of
IL-6 in the development of arthritogenic Th17 cells in SKG mice
(36), we examined in vitro responsiveness of SKG and WT CD4
T cells to IL-6. Phospho-flow cytometric analyses revealed that
SKGNur GFPhi CD4 T cells have higher basal levels of
phosphorylated-STAT3 (Y705) than GFPlo CD4 T cells (Fig. 5 A
and B). This difference was not observed among comparable
populations from unstimulated WTNur CD4 T cells. Interest-
ingly, inducible STAT3 phosphorylation in response to IL-6
stimulation in the GFPhi populations was more robust than
that of the GFPlo populations, but this was observed in both
SKGNur and WTNur mice. The overall response to IL-6 stim-
ulation in both the SKGNur GFPhi and GFPlo CD4 T cells was
much greater than in the comparable populations obtained from
WTNur CD4 T cells (Fig. 5 A and B). To investigate whether IL-
6 hyperresponsiveness in SKG mice was due to differences in
total STAT3 protein expression levels, we first compared the
expression levels of STAT3 between WT and SKG mice. As
shown in Fig. 5C, we found that STAT3 expression was com-
parable between WT and SKG CD4 T cells. To determine
whether this phenomenon was isolated to IL-6 or whether it
occurred with other cytokines that signaled through STAT3, we
examined the effects of IL-27—an IL-6–related cytokine—on
GFPhi and GFPlo CD4 T cells. GFPhi CD4 T cells were also more
sensitive to IL-27 stimulation from both WTNur and SKGNur
mice (SI Appendix, Fig. S7). However, IL-27 is unlikely to con-
tribute to arthritis development in view of its role of limiting
T cell-driven pathology, in part, by antagonizing the actions of IL-6
and restricting the expansion of Th17 cells (44, 45).
We next sought to examine the IL-6 pathway in greater detail
(Fig. 5D). We first analyzed the expression of both components
of the IL-6R, the ligand-binding IL-6Rα–chain CD126 and the
IL-6 family common receptor subunit gp130 (CD130), which is
essential for signal transduction following cytokine engagement
(46). As shown in Fig. 5 E and F, the GFPhi populations
expressed significantly higher amounts of CD130 than did the
GFPlo populations. However, there was no significant difference
in CD130 expression between WTNur and SKGNur mice. We
did observe minimal differential expression of CD126 protein
between the GFPhi and GFPlo populations, with lower amounts
expressed in the GFPhi T cell subset (Fig. 5 E and F). Although
the impact of the small differences is not clear, it may represent
shedding of IL-6Rα in response to CD4+ T cell activation (47,
48). These results indicate that the GFPhi and GFPlo populations
differ in their expression of CD130, perhaps contributing to
relatively increased IL-6 responses by GFPhi T cells.
Since these differences did not seem to account for the greater
IL-6 response in SKGNur mice, we further assessed key signaling
molecules downstream of the IL-6 signaling pathway, such as
Jak1, Jak2, and SOCS3. Similar to surface expression of CD130,
GFPhi CD4 T cells expressed higher amounts of Jak1 and Jak2
messenger RNA than did GFPlo CD4 T cells (Fig. 5G). Never-
theless, the expression levels of Jak1 and Jak2 transcripts were
comparable between the respective CD4 T cell populations iso-
lated from GFP populations in WTNur and SKGNur mice (Fig.
5G). Thus, increased expression of CD130, Jak1, and Jak2 in
GFPhi CD4 T cells might contribute to enhanced IL-6 responses
in this population, but both WTNur and SKGNur shared these
properties. Immunoblot analyses indicated that SOCS3 protein,
a key negative regulator of IL-6 signaling (49), was down-
regulated in SKGNur CD4 T cells (Fig. 5 H and I). Our results
suggest that the hyperresponsiveness to IL-6 observed in autor-
eactive SKGNur CD4 T cells exposed to chronic antigen stimu-
lation may be due, at least in part, to decreased SOCS3-dependent
suppression. We propose that SKGNur GFPhi CD4 T cells exhibit
uniquely robust IL-6 responses because they both up-regulate the
IL-6 proximal signaling machinery and coordinately express lower
levels of the negative regulator SOCS3. Other regulators of this
pathway could also influence the differential IL-6R responses of
T cells from the WT vs. SKG genotypes.
Nur77 Identifies Increased Frequencies of Antigen-Stimulated CD4 T
Cells in Arthritic SKG Synovium. A central challenge in isolating
bona fide antigen-activated T cells from inflamed arthritic joints in
patients with RA is differentiating these from T cells activated via
cytokines in the inflammatory milieu (50). Recently, we developed
technologies to detect induction of endogenous Nur77 protein fol-
lowing TCR and B cell receptor stimulation in mouse and human
T cells (21, 22, 24). Since Nur77 is induced downstream of TCR but
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not cytokine receptor signaling (Fig. 6A), and we observed in-
creased expression of Nur77-eGFP in arthritic joints of SKG mice
(Fig. 1A), we determined whether endogenous Nur77 protein was
also up-regulated in T cells after arthritis induction by zymosan
challenge in SKG mice. Indeed, when examining the CD4 T cell
population infiltrating arthritic SKG joints after zymosan treatment,
we found up-regulation of endogenous Nur77 protein in a subset of
CD4 T cells from SKG arthritic joints compared with nonarthritic
phosphate-buffered saline (PBS)–treated SKG mice (Fig. 6B and
gating in SI Appendix, Fig. S1D). Consistent with intracellular Nur77
expression, Nur77 transcript levels (Nr4a1) were increased ∼6-fold
in the population of joint-infiltrating CD4 T cells from zymosan-
treated SKG mice (Fig. 6C).
The discrepancy between the greater percentage of CD4
T cells expressing high GFP amounts (Fig. 1A) compared with
endogenous Nur77 may be due to the long in vivo half-life of
GFP in comparison to endogenous Nur77 (22), but it also sug-
gests a high degree of heterogeneity in the autoreactivity of the
CD4 T cell population within the arthritic joint. Together, these
data show that zymosan challenge in SKGNur mice, which trig-
gers activation of autoreactive CD4 T cells, led to up-regulation
of a population of cells that expressed higher levels of endoge-
nous Nur77 expression in the inflamed joints. Since Nur77 marks
antigen-dependent TCR signaling specifically, and the half-life
of endogenous Nur77 is short (51), these results suggest that a
subset of the joint-infiltrating CD4 T cells in SKG mice are
recognizing an intraarticular antigen(s).
Nur77 Protein, a Specific Indicator of TCR Signaling, Identifies
Increased Frequencies of Antigen-Stimulated CD4 T Cells in Human
RA Synovium. Utilizing methodology we optimized for intracel-
lular Nur77 staining in human lymphocytes (21), we used
endogenous Nur77 protein expression to determine whether
joint-infiltrating CD4 T cells in human RA patients might be
recognizing an intraarticular antigen, and as proof of concept to
establish whether this marker could, in turn, be subsequently
used to identify arthritogenic TCR specificities in RA patients.
We analyzed Nur77 expression in synovial T cells from 8 patients
undergoing a surgical joint procedure who met the American
College of Rheumatology classification criteria for seropositive
(rheumatoid factor or anti-CCP antibody–positive) RA (SI Ap-
pendix, Table S1). We found a significant increase in a fraction of
Nur77+ CD4 T cells isolated from synovial tissue from patients
with seropositive RA compared with matched peripheral blood
mononuclear cells (PBMCs) from the same donor (Fig. 6 D and E
and human gating in SI Appendix, Fig. S8), suggesting an enrichment
of antigen-reactive cells in the joint. Nur77 protein expression in
CD4 T cells obtained from the RA joints far exceeded that isolated
from synovial tissue of patients with a diagnosis of osteoarthritis, a
nonautoimmune degenerative form of arthritis (Fig. 6 D and F and
SI Appendix, Fig. S8). Importantly, the enrichment of endogenous
Nur77 was only observed in synovial infiltrating CD4 T cells and not
in CD8 T cells in RA synovium (Fig. 6D), consistent with the genetic
link to specific MHC class II alleles and the role of CD4 T cells in
the pathogenesis of RA (3–6, 8). These results support the hypoth-
esis that pathogenic CD4 T cells are enriched in RA joints and are
likely recognizing an intraarticular autoantigen(s).
SOCS3 Transcripts Are Down-Regulated in RA Synovial Tissue. Similar
to the SKG model, the pleiotropic cytokine IL-6 is thought to
contribute to the differentiation of Th17 cells in human RA, and
targeting the IL-6R with clinically used humanized monoclonal
antibodies leads to RA disease improvement (52, 53). Because
SOCS3 induction is critical to prevent prolonged and enhanced
IL-6 signaling in vivo (54), we wanted to investigate whether
SOCS3 levels may be inappropriately reduced in patients with
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whiskers, 1.5× interquartile range). (H) Immunoblot analysis of SOCS3 and β-actin in unstimulated, negatively selected CD4 T cells from SKG and WT mice.
Data are representative of 3 experiments. (I) Quantification of SOCS3 protein levels normalized to β-actin pooled from 3 immunoblot experiments as shown in H,
with 11 to 12 mice in each group. **P < 0.01.
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RA, creating a permissive environment for IL-6 signaling as seen
in the SKG mouse model of arthritis. Indeed, Ye et al. (55)
found that peripheral CD4 T cells from patients with RA were
associated with an aberrant STAT3 signaling network and had, in
fact, down-regulated SOCS3 expression. We then searched
general public repository databases for available transcriptome
data from RA synovial tissue. Thirteen studies met our inclusion
criteria, comprising over 300 bulk synovial samples (SI Appendix,
Table S2). Leveraging all collected publicly available microarray
data, we specifically looked into the SOCS3 gene. We found that
SOCS3 was down-regulated in RA synovial tissue compared with
healthy controls with a fold change of 0.61 and P value of 5E-11
(Fig. 7 A and B). Distribution plots per individual study are
shown in SI Appendix, Fig. S9. Furthermore, we interrogated the
expression of additional IL-6 signaling pathway components and
found minimal to no differences between patients with RA and
controls, apart from JAK2 (Fig. 7 B and C). These results suggest a
mechanism whereby IL-6 signaling may go unchecked and con-
tribute to persistent inflammatory responses in the RA joint. Some
of these differences may relate to differences in cell type and in-
flammatory state between RA and healthy control synovium.
Studies are underway to investigate whether infiltrating CD4
T cells from RA synovium contribute to this phenotype.
Discussion
Here, we describe an innovative approach, through the detection
and monitoring of Nur77 expression, to distinguish putative
autoreactive T cells with increased arthritogenic potential from
T cells activated by cytokine signaling. Indeed, we find an en-
richment of intracellular Nur77+ CD4 T cells in both human RA
and murine autoimmune arthritis. Although RA synovial tissue
has recently been phenotyped with attention placed on in-
filtrating “peripheral helper” T cells, little data exist on in-
filtrating T cell antigen reactivity or specificity (56–61). The
ability to identify Nur77+ CD4 T cells from RA synovial tissue
obtained from patients with well-established and, in most cases,
advanced “end-stage” joint disease suggests that antigen-specific
CD4 T cell responses continue to persist in diseased joints. While
we were able to exclude Tregs among the arthritogenic Nur77-
GFPhi cells in the joints of SKG mice, we could not do so when
endogenous Nur77 staining was used in patients. A subset of
these synovial Nur77+ CD4 T cells may include Tregs, although
Tregs make up only ∼10% of RA joint-infiltrating CD4 T cells
(62). Our future studies will further characterize the synovial
CD4 T cell subsets that express high levels of Nur77 (NR4A1)
using single-cell RNA sequencing. For clinical investigators,
these results highlight the importance of studying the relevant
tissues, rather than blood samples, to elucidate antigen-driven
events in relevant target tissues.
The ability to use Nur77 to track antigen-activated T cells
influenced our decision to take advantage of the Nur77-eGFP
reporter to explore functional heterogeneity of the CD4 T cell
repertoire before and after frank autoimmune disease onset in
the SKG mouse model of arthritis. The SKGNur reporter
revealed the following: (1) SKG thymocytes are able to up-
regulate a reporter of TCR signaling during thymic positive se-
lection despite their severely impaired TCR signaling capability,
presumably due to high-affinity self-pMHC TCRs being selected;
(2) further TCR stimulation occurs in the periphery (due to
chronic autoantigen stimulation, further repertoire pruning, or
both); and (3) highly autoreactive, arthritogenic T cells, despite
(or rather because of) profound deficiency in their TCR signal
transduction capacity, are hyperresponsive to IL-6 stimulation
due, at least in part, to up-regulation of IL-6 signaling machinery
and decreased SOCS3 expression. This provides a mechanism
whereby an autoreactive repertoire with impaired TCR signaling,
as seen in the SKG model, is able to break tolerance, differen-
tiate more readily into pathological Th17 effector cells in the
presence of IL-6, and cause arthritis.
That SKGT cells with severely impaired signaling can effectively
differentiate into Th17 effector cells that mediate an inflammatory,
destructive arthritis akin to RA seems counterintuitive. Yet,
there are multiple reports linking immune deficiency with im-
mune dysregulation and autoimmunity (6, 26, 29, 30, 42, 63–65).
It has been suggested that the partial reduction in the number or
function of T cells can disturb a “tolerogenic balance,” and thereby
generate a combination of immunodeficiency and hyperimmune
dysregulation (65). The precise mechanism remains elusive, although
murine models suggest multiple factors are at play, including
selection of an autoimmune TCR repertoire, lymphopenia-
induced exaggerated homeostatic proliferation precipitating au-
toimmune disease, deficient Treg function, resistance to Treg
suppression, and T cell dysregulation causing failed induction of
anergy in autoreactive T cells despite chronic antigen stimulation
(42, 63). In addition to the SKG mouse model, the Zap70 allelic
series and LAT mutated mice reveal a causal link between im-
paired TCR signaling associated with immune dysregulation and
autoimmunity (35, 66–69). Similarly, mouse models with cyto-
kine signaling defects, such as in STAT5A/5B-deficient mice,
can also serve as examples of immunodeficiency and immune
dysregulation and suggest a synergistic role for cytokine sig-
naling in the activation of self-reactive T cells (65, 70).
The link between immunodeficiency and autoimmunity has
long been appreciated in humans. Perhaps it is most evident in
patients with primary immunodeficiency, where up to 20 to 25%
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Fig. 6. Reporter of TCR signaling can be used to identify antigen-activated
CD4 T cells in human RA synovium. (A) Depiction of Nur77 induction by TCR
signal transduction, but not cytokine signaling. (B) Histogram shows the
overlay of endogenous Nur77 protein levels in the infiltrating CD4+CD25−
T cells from joints of SKGNur mice treated with phosphate-buffered saline
(PBS) or zymosan. Data are representative of >10 mice in at least 5 in-
dependent experiments. (C) Comparison of messenger RNA transcript levels
of Nr4A1 (Nur77) in sorted CD4+CD25− T cells from lymph nodes (LNs) or
joints of SKGNur mice treated with either PBS or zymosan (Zym). Each dot
represents a biologically independent sample pooled from 2 independent
experiments with 3 mice per group (mean ± SEM), using repeated measures
ANOVA. ***P ≤ 0.001. ns, not significant. (D, Top) Flow cytometry plots of
RA and osteoarthritis (OA) synovial tissue T cells demonstrate T cell pop-
ulations from LiveCD45+ RA and OA synovium. PerCP-Cy5.5, Peridin–
Chlorophyll–protein Cyanine5.5. (D, Bottom) Histograms represent Nur77
expression in CD4 (gate I) and CD8 (gate II) T cells from synovial RA (red) and
OA (green) tissue, RA PBMCs (blue), and isotype control (filled-in gray his-
togram). PE, phycoerythrin; % of max, percentage of maximum. Dot plots
demonstrate percentage of Nur77+ CD4 T cells (gate I) from paired RA
PBMCs and joints (n = 6) (E) and percentage of Nur77+ CD4 T cells from 8 RA
and 8 OA synovial tissues (F). *P ≤ 0.05 and ***P ≤ 0.001 by 2-tailed Stu-
dent’s t test. Each dot represents a biologically independent sample (mean ±
SEM).
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may develop autoimmune cytopenias, RA, or other autoimmune
diseases (71–73). The greatest risk has been associated with
partial T cell immunodeficiencies and common variable immu-
nodeficiency (73). The reverse association has also been de-
scribed. In the setting of primary autoimmunity, despite the
presence of activated immune cells mediating disease, observa-
tional studies have found an increased susceptibility to serious
infections (independent of immune-suppressive medications)
and premature aging of the immune system, suggesting that
impaired immune function might be a primary defect that, in
turn, subverts tolerance (74–77). For example, RA CD4 T cells
have the paradoxical ability to differentiate into pathogenic ef-
fector cells despite their impaired response to TCR engagement
(6, 7, 11–18). Importantly, this paradox is observed in the SKG
model of arthritis, making it one of the few mouse models to
capture the contribution of an autoreactive TCR repertoire with
impaired TCR signal transduction to the pathogenesis of arthritis.
Notably, our results uncover an unexpected mechanism for
initiation of autoimmune arthritis involving cross-talk in periph-
eral T cells between signaling via the TCR and responsiveness to
cytokine-dependent cues through IL-6R. We show that chronic
TCR stimulation of GFPhi T cells not only results in compensatory
changes in TCR signal transduction and inhibitory coreceptor
expression but also heightened sensitivity to IL-6 that is due, at
least in part, to increased expression of IL-6 signaling machinery,
as well as decreased expression of SOCS3. Since IL-6 signaling
drives the differentiation of CD4 T cells into arthritogenic Th17
effector cells and its presence is indispensable for arthritis devel-
opment in SKG mice, our observations provide a mechanistic link
between T cell self-reactivity and pathogenicity (36). While IL-6 is
critically important for the differentiation of CD4 T cells into IL-
17–secreting CD4 Th cells, it is also possible that IL-6R signaling
integrates with TCR signaling to promote survival of autoreactive
T cells in the SKG mouse. Limited literature exists on the inte-
gration of TCR and IL-6 cytokine signaling in this capacity. Their
coincident responses may create a feed-forward loop whereby the
presence of IL-6 protects CD4 T cells from activation-induced cell
death, promotes their expansion and survival in the periphery, and
participates in an IL-17A/IL-6–positive feedback loop promoting
autoimmunity (78, 79). Further efforts delineating the networks
involved in TCR and cytokine signaling integration in the setting
of chronic (auto)antigen stimulation are underway.
SOCS3 may provide an additional link between IL-6 and TCR
signaling networks (80, 81). SOCS3 is the most abundant of the
SOCS family member expressed in unstimulated naive T cells. Its
overexpression appears to inhibit TCR signaling and Th cell
proliferation (80, 82), whereas decreased SOCS3 activity has
been implicated in murine autoimmune arthritis (81–83) and in
human RA (55, 83–85). Furthermore, the suppression of SOCS3
by antigen stimulation of naive CD4 T cells has been reported
following acute TCR stimulation (80, 82). In this study, we pro-
pose that autoantigen-dependent stimulation of the skewed TCR
repertoire in SKG mice may lead to the observed SOCS3 sup-
pression in their CD4 T cells. Suppression of SOCS3, possibly
driven by chronic autoantigen-dependent TCR signaling, may
also result in altered IL-6 and TCR regulation, further pro-
moting the arthritogenic potential of GFPhi cells in the SKGNur
mice. Additionally, we identified reports of gene expression in
RA synovium and found a highly significant reduction of SOCS3,
suggesting the aforementioned mechanism may be relevant in
RA and related autoimmune diseases. These results will need to
be validated in CD4 synovial T cells from patients with RA.
Further work delineating the regulation of SOC3 in the setting of
chronic (auto)antigen stimulation remains to be determined.
Thus, our study highlights the functional importance of iden-
tifying and studying the arthritogenic T cell population in SKG
mice both before and after frank disease initiation, with trans-
latable implications for human RA. Further dissection of the
altered TCR and cytokine signaling networks in arthritogenic
human CD4 T cells may expand our understanding of RA path-
ogenesis and, in so doing, may reveal targets for novel therapeutic
approaches to RA. In addition, our study lays the groundwork for
the identification of arthritogenic T cell clones and their receptors,
as well as bona fide autoantigens not only in the SKG model but
also in human RA. Our work also provides a platform for inves-
tigators to identify autoantigen-specific T cells in other immuno-
logically mediated human diseases in which the inciting antigen is
not known—autoimmunity, cancer, and checkpoint blockade, as
well as transplant rejection.
Methods
Data Reporting. No statistical methods were used to predetermine sample
size. The human studies were not randomized, and the investigators were not
blinded to allocation during experiments and outcome assessment.
Mice. BALB/c and SCID BALB/c mice were purchased from The Jackson Lab-
oratory, and SKG and Nur77-eGFP Tg mice were kindly provided by Shimon
Sakaguchi, Kyoto University, Kyoto, Japan, and Julie Zikherman, University of
California, San Francisco (UCSF), respectively. Nur77-eGFP mice were back-
crossed to BALB/cmore than 8 times and crossed to SKGmice tomake SKGNur
mice. All mice were housed and bred in specific pathogen-free conditions in
the Animal Barrier Facility at UCSF according to the University Animal Care
Committee and NIH guidelines. All animal experiments were approved by the
UCSF Institutional Animal Care and Use Committee.
In Vivo Treatments. ZymosanA (Sigma–Aldrich) suspended in saline at 10mg/mL
was kept in boiling water for 10 min. Zymosan A solution (2 mg) or saline
was intraperitoneally injected into 8- to 12-wk-old mice. Adoptive transfer
experiments were performed as described (26, 40). The highest and lowest
5% Nur77-eGFP–purified CD4 T cells sorted on naive (CD62LhiCD44lo) or
memory (CD62LloCD44hi) markers and depleted of the Treg marker CD25
were adoptively transferred by tail vein injection into SCID recipients. To
prevent complications of weight loss and early onset of inflammatory bowel
disease after adoptive transfer of naive SKG T cells, WT Tregs were added
back in a ratio of 1:3.
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Fig. 7. Comparison of gene expression levels in synovium from patients
with RA. The gene expression values were log2-transformed and z-scaled.
The gene expression levels are summarized in the form of mean ± SEM. (A)
Synovial SOCS3 expression levels. (B) Table with summary statistics for genes
in the IL-6 signaling pathway. FC, fold change. (C) Expression levels for IL6ST,
IL6R, JAK1, JAK2, and STAT3 genes. P values were computed by performing
the nonparametric 2-sample Mann–Whitney–Wilcoxon test. ****P < 0.0001.
ns, not significant.
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Histology and Histopathology Scoring Criteria. Ankle joints were fixed in
buffered 10% formalin, and paraffin-embedded sections were decalcified
and stained with hematoxylin and eosin by the UCSF mouse pathology core.
Ankle joints were scored in a blinded fashion using a modified protocol (86).
Further details are provided in SI Appendix. A sum total (all joints) animal
score was determined. Parameters for the various groups were then com-
pared using Student’s t test.
Murine Synovial Tissue Preparation. Synovial tissues from ankle joints were
digested with 1 mg/mL Collagenase IV (Worthington) in RPMI 1640 medium
for 1 h at 37 °C; digested cells were filtrated through a nylon mesh to
prepare single-cell suspensions.
Complementary DNA Synthesis and qRT-PCR. Total RNA was purified using
TRIzol (Invitrogen) or the RNeasy Micro Kit (QIAGEN). Complementary DNA
was synthesized using the SuperScript III First-Strand Synthesis System
(Invitrogen) according to the manufacturer’s instructions. TaqMan real-time
PCR was performed using TaqMan Real-Time PCR Master Mix (Invitrogen),
and TaqMan primer and probe were purchased from IDT. The relative
abundance of all target genes was normalized to the abundance of an in-
ternal reference gene. Primer sequences are provided in SI Appendix.
AMLR.The10%highest and lowestNur77-eGFP–sortedCD4+CD25−CD62LhiCD44lo
naive T cells from SKGNur and WTNur lymph node and spleen were labeled
with 5 μMCTV according to the manufacturer’s instructions (Life Technologies)
before culturing in a 1:10 ratio with 5 × 105 nonirradiated BALB/c splenic APCs
(prepared via Thy1.2+ cell depletion by MACS; Miltenyi Biotec) in a 96-well,
round-bottom plate in complete RPMI medium for 5 d. Cells were harvested
and stained with fixable Live/Dead stain, anti-CD4, and anti–TCR-β, and were
analyzed by flow cytometry. A FlowJo Proliferation Platform was used to
determine the percent divided.
Intracellular Nur77 Staining. Nur77 staining assays in murine and human cells
were performed as previously described (21). All other intracellular staining
methods can be found in SI Appendix.
Human Research. Research involving human subjects was performed
according to the UCSF Institutional Review Board (IRB) through an approved
protocol (IRB no. 13-11485) with appropriate informed consent as required.
Patients with seropositive RA fulfilled the American College of Rheumatology
2010 RA classification criteria.
Patient Identification for Synovial Tissue. Through use of the UCSF Clinical
Data Research Consultations Office, patients with seropositive RA referred to
UCSF orthopedic surgery and scheduled for joint replacement, synovial bi-
opsy, or synovectomy were identified through data extraction of the UCSF
Medical Center’s electronic medical records and recruited to the study. A
discussion of patient inclusion/exclusion criteria and synovial tissue disag-
gregation is provided in SI Appendix.
Human PBMC Preparation. Whole human blood was collected from patients
with RA undergoing joint surgery in BD Vacutainer tubes (Becton Dickinson)
lined with sodium heparin and gently mixed. Monocytes were isolated by
density gradient Ficoll separation as previously described (21).
Genomic Data Collection and Preprocessing. A comprehensive search for
publicly available microarray data at the National Center for Biotechnology
Information Gene Expression Omnibus (87) database (https://www.ncbi.
nlm.nih.gov/geo/) was performed. The keywords “rheumatoid arthritis,”
“synovium,” “synovial,” and “biopsy” among organism “Homo sapiens” and
study type “Expression profiling by array”were used. The criteria for the dataset
exclusion from the search results were the lack of annotations and low probe
platforms. We were able to collect 13 datasets with 312 synovial biopsies (SI
Appendix, Table S2). Among them, there were 276 samples with an RA diagnosis
confirmed in later follow-ups and 36 healthy tissue biopsies obtained from joint or
trauma surgery. The gene expression measurements were made on 4
platforms from the manufacturers Affymetrix and Illumina and using 2
custom noncommercial chips. A discussion of raw data preprocessing is
provided in SI Appendix.
Statistics. Results from independent experiments were pooled whenever
possible; all data were analyzed by comparison of means using paired or
unpaired 2-tailed Student’s t tests using Prism version 5.0f for Mac (Graph-
Pad Software). Data in all figures represent mean ± SEM unless otherwise
indicated. Differences were considered significant at P < 0.05: *P < 0.05,
**P < 0.01, ***P < 0.001, and ****P < 0.0001.
Additional details on materials and methods are provided in SI Appendix,
including antibodies used, flow cytometry, intracellular staining methods,
calcium mobilization, in vitro proliferation assay, and immunoblot analysis.
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